Viewing Study NCT00632203


Ignite Creation Date: 2025-12-24 @ 7:09 PM
Ignite Modification Date: 2025-12-28 @ 2:47 AM
Study NCT ID: NCT00632203
Status: TERMINATED
Last Update Posted: 2017-06-07
First Post: 2008-02-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-03-04
Start Date Type: ACTUAL
Primary Completion Date: 2011-01-06
Primary Completion Date Type: ACTUAL
Completion Date: 2011-01-07
Completion Date Type: ACTUAL
First Submit Date: 2008-02-29
First Submit QC Date: None
Study First Post Date: 2008-03-10
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2011-12-22
Results First Submit QC Date: None
Results First Post Date: 2012-03-26
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-05-15
Last Update Post Date: 2017-06-07
Last Update Post Date Type: ACTUAL